Evidence map›Paper›PMID 27491295›Full record

ArticleAuto- immunity highlights2016

Reactive oxygen species in organ-specific autoimmunity.

Giulia Di Dalmazi, Jason Hirshberg, Daniel Lyle, Joudeh B Freij, Patrizio Caturegli

Open access · diamondAbstract read
In one paragraph

Article in Auto- immunity highlights, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Role of oxeiptosis in disease mechanisms and therapeutic opportunities.Apoptosis : an international journal on programmed cell death · 2025
    Review
  7. Article
  8. The Role of NADPH Oxidase 2 in Leukocytes.Antioxidants (Basel, Switzerland) · 2025
    Review
  9. Review
  10. Review
  11. Identification of active compounds inFrontiers in pharmacology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Giulia Di DalmaziDivision of Immunology, Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Jason HirshbergDepartment of Biochemistry and Molecular Biology, The Johns Hopkins School of Public Health, Baltimore, MD, USA.
Daniel LyleDepartment of Biochemistry and Molecular Biology, The Johns Hopkins School of Public Health, Baltimore, MD, USA.
Joudeh B FreijDepartment of Molecular Microbiology and Immunology, The Johns Hopkins School of Public Health, Baltimore, MD, USA.
Patrizio CaturegliDivision of Immunology, Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA. pcat@jhmi.edu.ORCID http://orcid.org/0000-0001-6768-6308
Johns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species (ROS) have been extensively studied in the induction of inflammation and tissue damage, especially as it relates to aging. In more recent years, ROS have been implicated in the pathogenesis of autoimmune diseases. Here, ROS accumulation leads to apoptosis and autoantigen structural changes that result in novel specificities. ROS have been implicated not only in the initiation of the autoimmune response but also in its amplification and spreading to novel epitopes, through the unmasking of cryptic determinants. This review will examine the contribution of ROS to the pathogenesis of four organ specific autoimmune diseases (Hashimoto thyroiditis, inflammatory bowel disease, multiple sclerosis, and vitiligo), and compare it to that of a better characterized systemic autoimmune disease (rheumatoid arthritis). It will also discuss tobacco smoking as an environmental factor endowed with both pro-oxidant and anti-oxidant properties, thus capable of differentially modulating the autoimmune response.

Indexed as

AutoimmunityHashimoto thyroiditisMonoamine oxidase (MAO)Oxidative stressReactive oxygen species (ROS)Smoking

Identifiers

PMID27491295
PMCPMC4974204
OpenAlexW2498964780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.